Amylyx Pharmaceuticals (AMLX)'s 30-day implied volatility (IV30) was 46.6% at the close on October 29, 2026, up from 38.2% the day before, against a 52-week range of 38.2% to 252.4%. Its 20-day historical volatility was 50.7%.
Data as of October 29, 2026.